Copyright Reports & Markets. All rights reserved.

Global Marburg Hemorrhagic Fever Drug Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Marburg Hemorrhagic Fever Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Marburg Hemorrhagic Fever Drug Market Size Growth Rate by Product
      • 1.4.2 Marburg Vaccine
      • 1.4.3 AVI-7288
      • 1.4.4 TKM-Marburg
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Marburg Hemorrhagic Fever Drug Market Size Growth Rate by End User
      • 1.5.2 Clinic
      • 1.5.3 Hospital
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Marburg Hemorrhagic Fever Drug Market Size
      • 2.1.1 Global Marburg Hemorrhagic Fever Drug Revenue 2014-2025
      • 2.1.2 Global Marburg Hemorrhagic Fever Drug Sales 2014-2025
    • 2.2 Marburg Hemorrhagic Fever Drug Growth Rate by Regions
      • 2.2.1 Global Marburg Hemorrhagic Fever Drug Sales by Regions
      • 2.2.2 Global Marburg Hemorrhagic Fever Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Marburg Hemorrhagic Fever Drug Sales by Manufacturers
      • 3.1.1 Marburg Hemorrhagic Fever Drug Sales by Manufacturers
      • 3.1.2 Marburg Hemorrhagic Fever Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Marburg Hemorrhagic Fever Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Marburg Hemorrhagic Fever Drug Revenue by Manufacturers
      • 3.2.1 Marburg Hemorrhagic Fever Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Marburg Hemorrhagic Fever Drug Revenue Share by Manufacturers (2014-2019)
    • 3.3 Marburg Hemorrhagic Fever Drug Price by Manufacturers
    • 3.4 Marburg Hemorrhagic Fever Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Marburg Hemorrhagic Fever Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Marburg Hemorrhagic Fever Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Marburg Hemorrhagic Fever Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Marburg Hemorrhagic Fever Drug Sales by Product
    • 4.2 Global Marburg Hemorrhagic Fever Drug Revenue by Product
    • 4.3 Marburg Hemorrhagic Fever Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Marburg Hemorrhagic Fever Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Marburg Hemorrhagic Fever Drug by Countries
      • 6.1.1 North America Marburg Hemorrhagic Fever Drug Sales by Countries
      • 6.1.2 North America Marburg Hemorrhagic Fever Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Marburg Hemorrhagic Fever Drug by Product
    • 6.3 North America Marburg Hemorrhagic Fever Drug by End User

    7 Europe

    • 7.1 Europe Marburg Hemorrhagic Fever Drug by Countries
      • 7.1.1 Europe Marburg Hemorrhagic Fever Drug Sales by Countries
      • 7.1.2 Europe Marburg Hemorrhagic Fever Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Marburg Hemorrhagic Fever Drug by Product
    • 7.3 Europe Marburg Hemorrhagic Fever Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Marburg Hemorrhagic Fever Drug by Countries
      • 8.1.1 Asia Pacific Marburg Hemorrhagic Fever Drug Sales by Countries
      • 8.1.2 Asia Pacific Marburg Hemorrhagic Fever Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Marburg Hemorrhagic Fever Drug by Product
    • 8.3 Asia Pacific Marburg Hemorrhagic Fever Drug by End User

    9 Central & South America

    • 9.1 Central & South America Marburg Hemorrhagic Fever Drug by Countries
      • 9.1.1 Central & South America Marburg Hemorrhagic Fever Drug Sales by Countries
      • 9.1.2 Central & South America Marburg Hemorrhagic Fever Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Marburg Hemorrhagic Fever Drug by Product
    • 9.3 Central & South America Marburg Hemorrhagic Fever Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Marburg Hemorrhagic Fever Drug by Countries
      • 10.1.1 Middle East and Africa Marburg Hemorrhagic Fever Drug Sales by Countries
      • 10.1.2 Middle East and Africa Marburg Hemorrhagic Fever Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Marburg Hemorrhagic Fever Drug by Product
    • 10.3 Middle East and Africa Marburg Hemorrhagic Fever Drug by End User

    11 Company Profiles

    • 11.1 GlaxoSmithKline plc
      • 11.1.1 GlaxoSmithKline plc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GlaxoSmithKline plc Marburg Hemorrhagic Fever Drug Products Offered
      • 11.1.5 GlaxoSmithKline plc Recent Development
    • 11.2 Immunovaccine, Inc.
      • 11.2.1 Immunovaccine, Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Immunovaccine, Inc. Marburg Hemorrhagic Fever Drug Products Offered
      • 11.2.5 Immunovaccine, Inc. Recent Development
    • 11.3 Integrated BioTherapeutics, Inc.
      • 11.3.1 Integrated BioTherapeutics, Inc. Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Integrated BioTherapeutics, Inc. Marburg Hemorrhagic Fever Drug Products Offered
      • 11.3.5 Integrated BioTherapeutics, Inc. Recent Development
    • 11.4 Sarepta Therapeutics, Inc.
      • 11.4.1 Sarepta Therapeutics, Inc. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sarepta Therapeutics, Inc. Marburg Hemorrhagic Fever Drug Products Offered
      • 11.4.5 Sarepta Therapeutics, Inc. Recent Development
    • 11.5 Tekmira Pharmaceuticals Corp.
      • 11.5.1 Tekmira Pharmaceuticals Corp. Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Tekmira Pharmaceuticals Corp. Marburg Hemorrhagic Fever Drug Products Offered
      • 11.5.5 Tekmira Pharmaceuticals Corp. Recent Development
    • 11.6 Vaxart, Inc
      • 11.6.1 Vaxart, Inc Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Vaxart, Inc Marburg Hemorrhagic Fever Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Vaxart, Inc Marburg Hemorrhagic Fever Drug Products Offered
      • 11.6.5 Vaxart, Inc Recent Development

    12 Future Forecast

    • 12.1 Marburg Hemorrhagic Fever Drug Market Forecast by Regions
      • 12.1.1 Global Marburg Hemorrhagic Fever Drug Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Marburg Hemorrhagic Fever Drug Revenue Forecast by Regions 2019-2025
    • 12.2 Marburg Hemorrhagic Fever Drug Market Forecast by Product
      • 12.2.1 Global Marburg Hemorrhagic Fever Drug Sales Forecast by Product 2019-2025
      • 12.2.2 Global Marburg Hemorrhagic Fever Drug Revenue Forecast by Product 2019-2025
    • 12.3 Marburg Hemorrhagic Fever Drug Market Forecast by End User
    • 12.4 North America Marburg Hemorrhagic Fever Drug Forecast
    • 12.5 Europe Marburg Hemorrhagic Fever Drug Forecast
    • 12.6 Asia Pacific Marburg Hemorrhagic Fever Drug Forecast
    • 12.7 Central & South America Marburg Hemorrhagic Fever Drug Forecast
    • 12.8 Middle East and Africa Marburg Hemorrhagic Fever Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Marburg Hemorrhagic Fever Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Marburg Hemorrhagic Fever Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Marburg Hemorrhagic Fever Drug market based on company, product type, end user and key regions.

      This report studies the global market size of Marburg Hemorrhagic Fever Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Marburg Hemorrhagic Fever Drug in these regions.
      This research report categorizes the global Marburg Hemorrhagic Fever Drug market by top players/brands, region, type and end user. This report also studies the global Marburg Hemorrhagic Fever Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GlaxoSmithKline plc
      Immunovaccine, Inc.
      Integrated BioTherapeutics, Inc.
      Sarepta Therapeutics, Inc.
      Tekmira Pharmaceuticals Corp.
      Vaxart, Inc

      Market size by Product
      Marburg Vaccine
      AVI-7288
      TKM-Marburg
      Others
      Market size by End User
      Clinic
      Hospital
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Marburg Hemorrhagic Fever Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Marburg Hemorrhagic Fever Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Marburg Hemorrhagic Fever Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Marburg Hemorrhagic Fever Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Marburg Hemorrhagic Fever Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Marburg Hemorrhagic Fever Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now